Letter to the Editor on Pastores et al. Development of anti-velaglucerase alfa antibodies in clinical trial-treated patients with Gaucher disease.

Blood Cells Mol Dis

Vice President and Head of Global Medical Affairs, Rare Diseases, Sanofi Genzyme, United States.

Published: May 2017

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2017.02.008DOI Listing

Publication Analysis

Top Keywords

letter editor
4
editor pastores
4
pastores development
4
development anti-velaglucerase
4
anti-velaglucerase alfa
4
alfa antibodies
4
antibodies clinical
4
clinical trial-treated
4
trial-treated patients
4
patients gaucher
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!